Exploration of Cytochrome P450 Inhibition Mediated DrugDrug Interaction Potential of Kratom Alkaloids.: In vitro cytochrome P450 inhibition of major kratom alkaloids mitragynine MTG speciogynine SPG speciocilliatine SPC corynantheidine COR… https://t.co/Y8Taa5ePIC
Exploration of cytochrome P450 inhibition mediated drug-drug interaction potential of kratom alkaloids.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Nov 2019 – Sep 2021Where it's discussed
-
YouTube2 videos
-
Reddit2 posts
-
News2 articles
-
X / Twitter1 posts
AI synopsis
What people are saying
Several discussions highlight the significance of the research by mentioning specific enzymes like CYP2D6 and the potential for adverse drug interactions, with phrases such as 'significant interactions' and 'may cause serious effects'. The tone varies from cautious to analytical, reflecting a shared interest in understanding kratom's health implications and the study's potential to impact medical approaches.
Most discussions align with the importance of the research, emphasizing the potential risks associated with kratom alkaloids and drug interactions.
Participants show high curiosity about the implications, mentioning specific enzymes and potential adverse effects.
The posts include detailed references to enzyme mechanisms and implications, indicating moderate depth of engagement.
The discussions suggest the findings could influence future research or clinical considerations, although some posts remain cautiously optimistic.
Abstract in brief
- Mitragynine (MTG) and corynantheidine (COR) were found to be strong inhibitors specifically of the CYP2D6 enzyme, which plays a major role in processing many drugs, and they block this enzyme through a competitive mechanism.
- The study suggests that coadministration of kratom containing MTG and COR could cause significant interactions with other medications metabolized by CYP2D6, potentially leading to adverse effects, while effects on other CYP enzymes (like CYP3A4) were minimal or specific to certain substrates.]
Top posts
Most liked on X and BlueskyAll mentions
Kratom Research and Pharmacokinetics Insights by Dr. Sharma
Dr. Abhisheak Sharma, a pharmacokineticist and kratom researcher, discusses kratom's alkaloid analysis, plant cultivation at the University of Florida, and current human clinical trials, highlighting the latest…
Kratom Pharmacodynamics and Alkaloid Interactions Explained
Dr. Lance McMahon, Chair at University of Florida College of Pharmacy, discusses kratom's mechanism of action, alkaloid interactions, and research updates including effects on brain receptors and opioid implications.
Exploration of Cytochrome P450 Inhibition Mediated DrugDrug Interaction Potential of Kratom Alkaloids.: In vitro cytochrome P450 inhibition of major kratom alkaloids mitragynine MTG speciogynine SPG speciocilliatine SPC corynantheidine COR… https://t.co/Y8Taa5ePIC
DN